Cargando…

Let's Be Clear about Expected Cardiovascular Risk: A Commentary on the Massive Rise in LDL Cholesterol Induced by Carbohydrate Restriction in the Proposed “Lean Mass Hyper-Responder” Phenotype

Detalles Bibliográficos
Autor principal:	Mindrum, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154254/ https://www.ncbi.nlm.nih.gov/pubmed/35669044 http://dx.doi.org/10.1093/cdn/nzac042

Ejemplares similares

Elevated LDL Cholesterol with a Carbohydrate-Restricted Diet: Evidence for a “Lean Mass Hyper-Responder” Phenotype
por: Norwitz, Nicholas G, et al.
Publicado: (2021)

Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet
por: Norwitz, Nicholas G., et al.
Publicado: (2022)

Evidence for a Lean Mass Hyperresponder Phenotype Is Lacking with Increases in LDL Cholesterol of Clinical Significance in All Categories of Response to a Carbohydrate-Restricted Diet
por: Moore, Jeff M, et al.
Publicado: (2022)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Plasma levels of soluble tumor necrosis factor-α receptors are related to total and LDL-cholesterol in lean, but not in obese subjects
por: Straczkowski, Marek, et al.
Publicado: (2006)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Commentary: Let's start again!
por: Miceli, Antonio
Publicado: (2022)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Let’s rise up to unite taxonomy and technology
por: Bik, Holly M.
Publicado: (2017)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

γGT and PCSK9 variants in subjects with hyper-LDL-cholesterolemia
por: Hamasaki, Masato, et al.
Publicado: (2022)

Elevation in white blood cell count and development of hyper LDL cholesterolemia
por: Okutsu, Shota, et al.
Publicado: (2023)

Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
por: Ravnskov, Uffe, et al.
Publicado: (2022)

Commentary: Let's just celebrate this win
por: Klapper, Jacob A.
Publicado: (2021)

The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

LDL Cholesterol and Dysglycemia: an Intriguing Physiological Relationship
por: Merino, Jordi, et al.
Publicado: (2020)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

What to Expect From Corporate Lean Programs
por: Ferdows, Kasra
Publicado: (2014)

Extra-metabolic energy use and the rise in human hyper-density
por: Burger, Joseph R., et al.
Publicado: (2017)

Carbohydrate restriction and dietary cholesterol modulate the expression of HMG-CoA reductase and the LDL receptor in mononuclear cells from adult men
por: Mutungi, Gisella, et al.
Publicado: (2007)

Lung Adenocarcinoma with Paraneoplastic Hyper-Eosinophilia Not Responding To Pembrolizumab
por: Wehbe, Hisham, et al.
Publicado: (2021)

Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C
por: Taylor, Beth A., et al.
Publicado: (2014)

Commentary: Expecting the unexpected
por: Akhmerov, Akbarshakh, et al.
Publicado: (2021)

Comparison of calculated LDL-cholesterol using the Friedewald formula and de Cordova formula with a directly measured LDL-cholesterol in Nepalese population
por: Pradhan, Santosh, et al.
Publicado: (2020)

Lean: let's get it right! : how to build a culture of continuous improvement
por: Rizzardo, David
Publicado: (2020)

Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol
por: Fukuyama, Naoto, et al.
Publicado: (2008)

Impact of oxLDL on Cholesterol-Rich Membrane Rafts
por: Levitan, Irena, et al.
Publicado: (2011)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
por: Skoczyńska, Anna, et al.
Publicado: (2015)

Korean public and hospital data for estimating LDL-cholesterol
por: Lee, Taesic, et al.
Publicado: (2018)

LDL–cholesterol transport to the endoplasmic reticulum: current concepts
por: Pfisterer, Simon G., et al.
Publicado: (2016)

Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023)

Comparison of Newly Proposed LDL-Cholesterol Estimation Equations
por: Jeong, Yong Whi, et al.
Publicado: (2023)

Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
por: Moriyama, Kengo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0o4qut6joam5nervvgd2aqohqr